Genetic research of mouse bone marrow mesenchymal stem cells subsets SCA-1+ / CD45+ / CD31+ itself anti-apoptotic ability

贺继刚,李洪荣,桂龙升,李永武,严丹,王平
DOI: https://doi.org/10.19405/j.cnki.issn1000-1492.2015.12.011
2015-01-01
Abstract:Objective To investigate the molecular basis of the anti-apoptosis effects of the SCA-1 +/ CD45 +/CD31 + subset of mice bone marrow mesenchymal stem cells ( BMSCs) . Methods After the mice cardiac stem cell surface differentiation antigen was used to detect the BMSCs, four subsets were obtained, with CD45, CD31 as the sorting standard. These four groups were grown in vitro in serum-free cultures under hypoxia (5%) . The apoptosis rate of each group was measured by flow cytometry. The cell cultures were injected into mice with 48 h myocardial infarction to determine the cardiac function after another 48 h. Among the four groups, the SCA-1 +/ CD45 +/CD31 + subset demonstrated the highest anti-apoptotic effect. Color sonography showed that the recovery of cardiac function in the SCA-1 +/ CD45 +/ CD31 + subset was relatively better than that in the other groups. An agilent whole mice genome 4 × 44 K chip was used to study the anti-apoptosis effects of the SCA-1 +/ CD45 +/ CD31 + sub-set at the molecular level. Results Clustering analysis and network of the apoptosis genes was performed on the SCA-1 +/ CD45 +/ CD31 + subset against the other subsets. Results of network and Clustering analysis showed the absence of an intersection between groups. A fourfold difference in the expression of the above mentioned genes were set as the standard for differential expression based on the network results. NFkB1, RB1, and E2F1 were i-dentified as the genes of interest. Conclusion BMSCs belong to a polyclonal cell population. The SCA-1 +/CD45 +/ CD31 + subset is relatively better than the other subsets in terms of its anti-apoptosis effects and improve-ment in cardiac function. The molecular mechanism of SCA-1 +/ CD45 +/ CD31 + activity may involve NFkB1, RB1 , and E2 F1 because the expression is more common in the SCA-1 +/ CD45 +/ CD31 + subset than in the other subsets.
What problem does this paper attempt to address?